ProQR Therapeutics N.V. (PRQR) PT Raised to $44 at Citi
Tweet
Share
E-mailGet Alerts PRQR Hot Sheet
Price: $1.92 +3.78%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on ProQR Therapeutics N.V. (NASDAQ: PRQR) to $44.00 (from $33.00) while maintaining a Buy rating.
You May Also Be Interested In
- ProQR Announces Second Quarter 2026 Operating and Financial Results
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
